These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 34755954)

  • 41. IgG testing, immunoglobulin replacement therapy, and infection outcomes in patients with CLL or NHL: real-world evidence.
    Soumerai JD; Yousif Z; Gift T; Desai R; Huynh L; Ye M; Banatwala A; Clear L; Pinaire M; Belsky G; Hsieh YG; Herrick C; Darnell EP; Duh MS; Sanchirico M; Murphy SN
    Blood Adv; 2024 Aug; 8(16):4239-4249. PubMed ID: 38904477
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Contributions of Subtypes of Non-Hodgkin Lymphoma to Mortality Trends.
    Howlader N; Morton LM; Feuer EJ; Besson C; Engels EA
    Cancer Epidemiol Biomarkers Prev; 2016 Jan; 25(1):174-9. PubMed ID: 26472423
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lymphoma-associated skin cancer: incidence, natural history, and clinical management.
    Brewer JD; Habermann TM; Shanafelt TD
    Int J Dermatol; 2014 Mar; 53(3):267-74. PubMed ID: 24320558
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hormone replacement therapy and risk of non-hodgkin lymphoma and chronic lymphocytic leukemia.
    Cerhan JR; Vachon CM; Habermann TM; Ansell SM; Witzig TE; Kurtin PJ; Janney CA; Zheng W; Potter JD; Sellers TA; Folsom AR
    Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1466-71. PubMed ID: 12433728
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Family history of hematopoietic malignancy and risk of lymphoma.
    Chang ET; Smedby KE; Hjalgrim H; Porwit-MacDonald A; Roos G; Glimelius B; Adami HO
    J Natl Cancer Inst; 2005 Oct; 97(19):1466-74. PubMed ID: 16204696
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Merkel Cell Carcinoma in a Patient With CLL/Atypical AML.
    Lipner SR
    J Cutan Med Surg; 2018; 22(3):324. PubMed ID: 29865947
    [No Abstract]   [Full Text] [Related]  

  • 47. Racial differences in three major NHL subtypes: descriptive epidemiology.
    Li Y; Wang Y; Wang Z; Yi D; Ma S
    Cancer Epidemiol; 2015 Feb; 39(1):8-13. PubMed ID: 25560974
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Merkel cell carcinoma: Clinical outcome and prognostic factors in 351 patients.
    van Veenendaal LM; van Akkooi ACJ; Verhoef C; Grünhagen DJ; Klop WMC; Valk GD; Tesselaar MET
    J Surg Oncol; 2018 Jun; 117(8):1768-1775. PubMed ID: 29790179
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prognosis of older adults with chronic lymphocytic leukemia: A Surveillance, Epidemiology, and End Results-Medicare cohort study.
    Duchesneau ED; McNeill AM; Schary W; Pate V; Lund JL
    J Geriatr Oncol; 2023 Nov; 14(8):101602. PubMed ID: 37696241
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Outcomes of Richter's transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL): an analysis of the SEER database.
    Elnair R; Ellithi M; Kallam A; Shostrom V; Bociek RG
    Ann Hematol; 2021 Oct; 100(10):2513-2519. PubMed ID: 34279675
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Merkel cell carcinoma-derived macrophage migration inhibitory factor (MIF) may promote persistence of Chronic Lymphocytic Leukemia.
    Alencar GF; Rodriguez HJ; Pulliam TH; Remington AJ; Gilmour MW; Alam R; Jabbour AJ; Mullen LJ; DeBuysscher BL; Nghiem P; Taylor JJ
    bioRxiv; 2024 Sep; ():. PubMed ID: 39345457
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Conditional survival estimates for merkel cell carcinoma reveal the dynamic nature of prognostication.
    Miura JT; Lindner H; Karakousis GC; Sharon CE; Gimotty PA
    J Surg Oncol; 2022 Aug; 126(2):348-355. PubMed ID: 35315930
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Veterans with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) have a markedly increased rate of second malignancy, which is the most common cause of death.
    Kyasa MJ; Hazlett L; Parrish RS; Schichman SA; Zent CS
    Leuk Lymphoma; 2004 Mar; 45(3):507-13. PubMed ID: 15160912
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pigmentary traits, sun exposure, and risk of non-Hodgkin's lymphoma/chronic lymphocytic leukemia: A study within the French E3N prospective cohort.
    Garcin LM; Gelot A; Gomez RR; Gusto G; Boutron-Ruault MC; Kvaskoff M; Severi G; Besson C
    Cancer Med; 2021 Jan; 10(1):297-304. PubMed ID: 33219744
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Systemic immune suppression predicts diminished Merkel cell carcinoma-specific survival independent of stage.
    Paulson KG; Iyer JG; Blom A; Warton EM; Sokil M; Yelistratova L; Schuman L; Nagase K; Bhatia S; Asgari MM; Nghiem P
    J Invest Dermatol; 2013 Mar; 133(3):642-646. PubMed ID: 23190897
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Absolute lymphocyte count: a potential prognostic factor for Merkel cell carcinoma.
    Johnson ME; Zhu F; Li T; Wu H; Galloway TJ; Farma JM; Perlis CS; Turaka A
    J Am Acad Dermatol; 2014 Jun; 70(6):1028-35. PubMed ID: 24666998
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Second primary cancers in patients with acute lymphoblastic, chronic lymphocytic and hairy cell leukaemia.
    Zheng G; Chattopadhyay S; Sud A; Sundquist K; Sundquist J; Försti A; Houlston R; Hemminki A; Hemminki K
    Br J Haematol; 2019 Apr; 185(2):232-239. PubMed ID: 30706458
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Risk factors associated with Richter's transformation in patients with chronic lymphocytic leukaemia: protocol for a retrospective population-based cohort study.
    Hleuhel MH; Ben-Dali Y; Da Cunha-Bang C; Brieghel C; Clasen-Linde E; Niemann CU; Andersen MA
    BMJ Open; 2019 Mar; 9(3):e023566. PubMed ID: 30833314
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Racial differences in the presentation and outcomes of chronic lymphocytic leukemia and variants in the United States.
    Shenoy PJ; Malik N; Sinha R; Nooka A; Nastoupil LJ; Smith M; Flowers CR
    Clin Lymphoma Myeloma Leuk; 2011 Dec; 11(6):498-506. PubMed ID: 21889433
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Statin use and survival in 16 098 patients with non-Hodgkin lymphoma or chronic lymphocytic leukaemia treated in the rituximab era.
    Brånvall E; Ekberg S; Eloranta S; Wästerlid T; Birmann BM; Smedby KE
    Br J Haematol; 2021 Nov; 195(4):552-560. PubMed ID: 34331461
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.